Author: dweetleapp

  • Navigating the Digital Shift with AUTOMA+ 2025

    Zisis Kozlakidis, Head, Laboratory Services at IARC/WHO reviewed patient-centric digital interaction in public health, highlighting the potential of integrated AI to accelerate discovery, enhance precision medicine and improve public health outcomes. As AUTOMA+ 2025 Technology Partner, Boehringer Ingelheim Pharma GmbH & Co.KG, with Joachim Bär, Director DevOps CellCulture, as speaker, presented a workshop on digital read more

    Written by

    dweetleapp
    Navigating the Digital Shift with AUTOMA+ 2025

  • BAt: Towards precision medicine for COPD

    The variability in what we observe in these patients has long challenged our ability to predict outcomes and tailor their treatment Neil Greening Associate Professor Dr Neil Greening from the University of Leicester’s Department of Respiratory Sciences and Honorary Consultant Respiratory Physician from University Hospitals of Leicester NHS Trust explains: “Exacerbations of COPD remain a read more

    Written by

    dweetleapp
    BAt: Towards precision medicine for COPD

  • JustiGuide wants to use AI to help people navigate the US immigration system  | TechCrunch

    The U.S. immigration system is complex, hard to navigate, and expensive for immigrants. The startup JustiGuide claims it can help with that thanks to an AI-powered portal. The idea is to help immigrants in the U.S. — and eventually in other countries — understand the law and what visas they may be eligible for, and read more

    Written by

    dweetleapp
    JustiGuide wants to use AI to help people navigate the US immigration system  | TechCrunch

  • OpenAI claims teen circumvented safety features before suicide that ChatGPT helped plan | TechCrunch

    In August, parents Matthew and Maria Raine sued OpenAI and its CEO, Sam Altman, over their 16-year-old son Adam’s suicide, accusing the company of wrongful death. On Tuesday, OpenAI responded to the lawsuit with a filing of its own, arguing that it shouldn’t be held responsible for the teenager’s death. OpenAI claims that over roughly read more

    Written by

    dweetleapp
    OpenAI claims teen circumvented safety features before suicide that ChatGPT helped plan | TechCrunch

  • Policy reform call to secure Europe’s antibiotics supply

    Supply crisis of antibiotics in Europe adds burden to regional efforts to overcome antimicrobial resistance (AMR), says a new report. Procurement reform, policy intervention and international regulatory leadership are all required to address a growing supply chain crisis for system-critical antibiotics in Europe. That’s according to a new report from healthcare consultancy Newmarket Strategy, and read more

    Written by

    dweetleapp
    Policy reform call to secure Europe’s antibiotics supply

  • GM tech executive shakeup continues on software team | TechCrunch

    The software team at General Motors has now lost three top executives in the past month as the automaker — with its new chief product officer at the helm — combines its disparate technology businesses into one organization. Baris Cetinok, senior vice president of software and services product management, is leaving the company effective December read more

    Written by

    dweetleapp
    GM tech executive shakeup continues on software team | TechCrunch

  • New macOS malware chain could cause a major security headache – heres what we know

    Jamf reports North Korean actors using fake job ads and ClickFix tactics to target macOS users Victims are tricked into running curl commands in Terminal, installing FlexibleFerret backdoor malware The campaign, dubbed Contagious Interview, enables credential theft, file exfiltration, and system compromise North Korean state-sponsored threat actors are targeting macOS users with new malware, utilizing read more

    Written by

    dweetleapp
    New macOS malware chain could cause a major security headache – heres what we know

  • Breaking down the boom in the Nordic's startup ecosystem | TechCrunch

    The always-a-good-time Slush conference took place last week in Helsinki and, as always, it was a showcase of the growing power of the European ecosystem. The Nordics, specifically, are having a moment, led this time around by Sweden’s vibe-coding darling Lovable, often regarded as an example of the ecosystem’s growing success. Other standout, albeit older read more

    Written by

    dweetleapp
    Breaking down the boom in the Nordic's startup ecosystem | TechCrunch

  • TSA May Start Charging Travelers Who Don’t Have a Real ID

    Showing up to the airport security checkpoint without the proper identification could soon cost you. TSA has proposed a new $18 fee for travelers who come to the airport without a Real ID as part of an alternate identity verification system that the agency plans to launch in the near future. According to a notice read more

    Written by

    dweetleapp
    TSA May Start Charging Travelers Who Don’t Have a Real ID

  • Musk’s xAI to build small solar farm adjacent to Colossus data center | TechCrunch

    Artificial intelligence startup xAI, founded by Elon Musk, told city and county planners in Memphis last week that it plans to build a solar farm next to its Colossus data center — one of the world’s largest facilities for training AI models. The project would occupy 88 acres to the west and to the south read more

    Written by

    dweetleapp
    Musk’s xAI to build small solar farm adjacent to Colossus data center | TechCrunch

  • Are you balding? There’s an AI for that | TechCrunch

    For Cyriac Lefort, the idea for his new startup, MyHair AI, came two years ago.The French native was sitting in a hair salon in New York getting a routine haircut when his hairdresser looked at him and said, “You’re starting to lose a bit of hair,” Lefort, who is 32, recalls being told. “He didn’t read more

    Written by

    dweetleapp
    Are you balding? There’s an AI for that | TechCrunch

  • Startups react to Autumn Budget, as the chancellor says ”if you build here, Britain will back you”

    UK startups have broadly welcomed measures introduced by the UK chancellor in the Autumn budget, designed to get entrepreneurs to scale their startups in the UK, which has been a long-running concern for the industry. However, the response from the fintech industry was mixed, with some praising the budget while others bemoaning that more was read more

    Written by

    dweetleapp
    Startups react to Autumn Budget, as the chancellor says ”if you build here, Britain will back you”

  • Architect David Adjaye Speaks Out Against Sexual Misconduct Allegations

    In some of his first public comments after being accused of sexual misconduct in 2023, David Adjaye lambasted the Financial Times story that detailed the allegations, calling it “deeply unfair”. Adding, “There was just an interest in just destroying me, and I got caught in a sort of version of the #MeToo slam.” As reported read more

    Written by

    dweetleapp
    Architect David Adjaye Speaks Out Against Sexual Misconduct Allegations

  • Pulitzer Prize-Winning Critic Christopher Knight Retires from the Los Angeles Times

    Renowned critic and commentator Christopher Knight is retiring after writing about art for some 45 years, including 36 years at the Los Angeles Times. Knight is among the few remaining full-time critics at magazines and newspapers. Friday is his final day. “It’s impossible to overstate the loss Knight’s departure represents for the paper and Los read more

    Written by

    dweetleapp
    Pulitzer Prize-Winning Critic Christopher Knight Retires from the Los Angeles Times

  • Medicines manufacturing in the UK to receive £54m boost

    R&D projects supported by the Centre for Process Innovation (CPI) aim to shape a sustainable, resilient and competitive future for pharma manufacturing. Innovate UK’s Sustainable Medicines Manufacturing Innovation Programme(SMMIP) is funding eight innovative R&D ‘Grand Challenge’ projects to make medicines manufacturing more efficient, smarter and sustainable. The Programme, part of 2024’sVoluntary Scheme for Branded Medicines read more

    Written by

    dweetleapp
    Medicines manufacturing in the UK to receive £54m boost

  • Clover raises €30M to become the go-to investor for work and education startups

    French Entrepreneur Samuel Tual has today launched Clover, a €30 million early-stage evergreen fund to back startups reshaping the future of work and education. Tual is an entrepreneur, Vice-President of the MEDEF and Chairman & CEO of Actual Group, a major player in employment and labour in France and Europe. Clover aims to become the read more

    Written by

    dweetleapp
    Clover raises €30M to become the go-to investor for work and education startups

  • Novartis adjusts manufacturing strategy in Switzerland

    Swiss pharma company to trim production of oral medicines and packaging in Stein, while boosting productivity in Schweizerhalle. To maintain competitive production in Switzerland, Novartis is restructuring its workforce, as well as investing in innovative technologies such as automation, according to the firm’s President of Operations, Steffen Lang. The changes involve cutting 550 jobs at read more

    Written by

    dweetleapp
    Novartis adjusts manufacturing strategy in Switzerland

  • First biosimilar version of J&J’s Simponi approved in Europe

    Authorisation of the biosimilar Gobivaz provides a substitute biologic medicine to Simponi for individuals with immune-mediated diseases. Alvotech’s Gobivaz biosimilar has been approved in Europe and once launched will offer competition to its originator product, Johnson & Johnson’s monoclonal antibody Simponi (golimumab). The authorisation is for Gobivaz®50 mg/0.5 mL and 100mg/mL in both pre-filled syringe read more

    Written by

    dweetleapp
    First biosimilar version of J&J’s Simponi approved in Europe

  • Biovectra teams up with Revolution Biomanufacturing in mRNA

    The companies’ partnership covers messenger RNA design and production services. 3D illustration of of a molecular model of messenger ribonucleic acid (mRNA) Biovectra has partnered with US contract development and manufacturing organisation (CDMO) Revolution Biomanufacturing on mRNA design and production. The collaboration combines sequence design expertise with end-to-end GMP manufacturing with the aim of streamlining read more

    Written by

    dweetleapp
    Biovectra teams up with Revolution Biomanufacturing in mRNA

  • Novartis opens third US radioligand manufacturing facility

    California site adds to the Swiss pharma company’s operations in Florida and Texas. Credit: Jonathan Weiss / Shutterstock.com Novartis has opened its third manufacturing facility for radioligand therapies, with a new site in Carlsbad, California joining existing locations in Florida and Texas. The move is part of the Swiss pharma company’s $23 billion US expansion read more

    Written by

    dweetleapp
    Novartis opens third US radioligand manufacturing facility